Burden of Disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma

BACKGROUND: Isolated limb infusion (ILI) with melphalan is a minimally invasive, effective treatment for in transit melanoma. We hypothesized that burden of disease (BOD) would correlate to treatment response. METHODS: We retrospectively analyzed a prospectively collected database from two academic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Surg Oncol
Päätekijät: Muilenburg, Diego J., Beasley, Georgia M., Thompson, Zachary J., Lee, Ji-Hyun, Tyler, Douglas S., Zager, Jonathan S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505812/
https://ncbi.nlm.nih.gov/pubmed/25192683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4072-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia